John Castellani news and information

Executives at large healthcare associations made healthy financial gains in 2011 as the industry continued to grapple with the transition and uncertainty of health reform.
FULL STORY »

The Pharmaceutical Research and Manufacturers of America named Dr. William Chin executive VP of science and regulatory affairs, effective July 1. Chin, the executive dean for research at Harvard Medical School, will report to PhRMA President and CEO...
FULL STORY »

The nominees for Modern Healthcare's 12th annual 100 Most Influential People in Healthcare competition.
FULL STORY »

Drug and device makers fear the White House's budget-cutting plans will undermine legislation intended to improve the reviews of new products.
FULL STORY »

The top lobbyist for the pharmaceutical industry on Thursday said his group will emphasize the successes of Medicare's Part D program as policymakers tackle the difficult task of Medicare reform.
FULL STORY »

Earnings for executives who run not-for-profit healthcare associations, as well as the organizations themselves, have seen somewhat of a reversal of fortunes, but in opposite directions.
FULL STORY »

An expansion of a coming Medicare saving panel included as part of President Barack Obama's 12-year $4 trillion debt-reduction proposal drew heavy criticism after the plan was released Wednesday.
FULL STORY »

The price index for a group of 100 commonly used prescription drugs increased at an average annual rate of 6.6% from 2006 through the first quarter of 2010, compared with an average increase of 3.8% in the medical consumer price index, which measures the costs of medical goods and services,...
FULL STORY »